PATRONE, FRANCO
 Distribuzione geografica
Continente #
EU - Europa 18.880
Totale 18.880
Nazione #
IT - Italia 18.880
Totale 18.880
Città #
Genova 15.194
Rapallo 2.224
Genoa 1.419
Bordighera 43
Totale 18.880
Nome #
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 172
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 171
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 169
Autophagy in blood cancers: biological role and therapeutic implications. 165
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 164
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 164
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 158
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 154
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. 154
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 149
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 148
Dynamic simulations of pathways downstream of TGF-β , Wnt and EGF-family grow- th factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 147
Anticancer vaccination strategies. 145
APO866 activity in hematologic malignancies: a preclinical in vitro study. 143
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 143
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 143
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 143
Ras-induced resistance to lapatinib is overcome by MEK inhibition 140
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 139
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 139
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 137
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 137
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 136
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 136
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 134
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 132
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 129
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 128
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 126
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 126
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 126
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 125
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 124
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 123
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 121
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 120
New insights into biology of chronic myeloid leukemia: implications in therapy. 120
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. 120
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 120
In vitro effects of synthetic chemotactic peptides on neutrophil function. 119
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide and cisplatin (CEP) 116
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 116
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 116
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 116
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 115
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 114
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. 114
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. 114
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 114
Stimulation of neutrophil locomotion by inosiplex. 113
Neutrophil functions in acne conglobata. 112
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 111
A simple acid-precipitation test for rapid screening of monoclonal gammopathies. 111
Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells. 111
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 111
The use of dendritic cells in cancer immunotherapy. 111
Hyperimmunoglobulinemia E syndrome. 110
Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. 110
The proteasome and its inhibitors in immune regulation and immune disorders. 109
Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. 109
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 109
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 108
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. 108
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer 107
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 107
Autologous peripheral blood stem cells (PBSC) in breast cancer. 107
Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. 107
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. 106
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 106
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 106
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 106
Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. 105
Neutrophil chemotaxis: physiology and pathology. 105
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 105
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 104
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 102
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 102
Intracellular NAD+ depletion induces autophagic-death in Multiple Myeloma cells 102
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 101
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 101
Proteasome inhibitors: antitumor effects and beyond 101
Immunopathological studies on a case of Sweet's syndrome. 100
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. 100
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 100
Target cell lysis mediated by concanavalin A-triggered human neutrophils. 100
Evidence for a reversible functional state of neutrophil chemotactic deactivation. 100
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 99
Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation. 99
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 98
Extracellular cytolysis by leukaemic blast cells. 98
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 97
Defective neutrophil chemotaxis and bactericidal power in a child with hyperimmunoglobulinemia E. 96
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 96
Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation. 96
Neutropenia and impaired neutrophil function in glycogenosis type Ib. 96
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 95
Repeated skin infections as a manifestation of lupus erythematosus. 95
Variant Philadelphia chromosome translocations are frequently associated with additional structural abnormalities. 94
Cellular cytotoxicity mediated by granule-depleted neutrophil cytoplasts. 94
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. 93
Totale 11.893
Categoria #
all - tutte 43.381
article - articoli 42.363
book - libri 0
conference - conferenze 243
curatela - curatele 0
other - altro 0
patent - brevetti 16
selected - selezionate 0
volume - volumi 759
Totale 86.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019851 0 0 0 0 0 0 0 0 0 0 463 388
2019/20205.241 223 143 238 319 471 515 937 301 391 908 587 208
2020/20211.248 109 101 71 78 80 130 76 107 130 117 146 103
2021/20222.418 58 183 172 257 178 145 129 540 78 245 110 323
2022/20232.674 271 198 18 293 442 492 14 201 464 12 244 25
2023/20241.014 44 161 24 149 103 271 43 142 54 22 1 0
Totale 18.981